Measuring dopamine neuromodulation in the thalamus: Using [F-18]fallypride PET to study dopamine release during a spatial attention task

NeuroImage

Volumn 31, Issue 1, 2006, Pages 139-152

  Christian, Bradley T ^a,b   Lehrer, Douglas S ^a,b   Shi, Bingzhi ^a   Narayanan, Tanjore K ^a   Strohmeyer, Pamela S ^a   Buchsbaum, Monte S ^c   Mantil, Joseph C ^a  

^a KETTERING MEDICAL CENTER   (United States)

^b WRIGHT STATE UNIVERSITY   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; DOPAMINE 2 RECEPTOR; FALLYPRIDE F 18; FLUORODEOXYGLUCOSE; RADIOLIGAND; UNCLASSIFIED DRUG;

ADULT; AMYGDALOID NUCLEUS; ARTICLE; ATTENTION; BLOOD FLOW; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DRUG BINDING; DRUG UPTAKE; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN EXPERIMENT; MALE; NEUROMODULATION; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TASK PERFORMANCE; TEMPORAL CORTEX; THALAMUS;

ADULT; ATTENTION; BENZAMIDES; BRAIN MAPPING; COGNITION; CORPUS STRIATUM; DOPAMINE; FEMALE; FLUORINE RADIOISOTOPES; HUMANS; MALE; NEUROTRANSMITTER AGENTS; ORIENTATION; POSITRON-EMISSION TOMOGRAPHY; PYRROLIDINES; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; THALAMUS;

EID: 33646569669     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2005.11.052     Document Type: Article

References (52)

1. Aalto S., Bruck A., Laine M., Nagren K., and Rinne J.O. Frontal and temporal dopamine release during working memory and attention tasks in healthy humans: a positron emission tomography study using the high-affinity dopamine D-2 receptor ligand [C-11]FLB 457. J. Neurosci. 25 10 (2005) 2471-2477
2. Akaike H. A new look at statistical model identification. IEEE Trans. Automat. Contr. 19 (1974) 716-723
3. Alpert N.M., Badgaiyan R.D., Livni E., and Fischman A.J. A novel method for noninvasive detection of neuromodulatory changes in specific neurotransmitter systems. NeuroImage 19 3 (2003) 1049-1060
4. Andersson J.L.R., Hutton C., Ashburner J., Turner R., and Friston K. Modeling geometric deformations in EPI time series. NeuroImage 13 5 (2001) 903-919
5. Aston J.A.D., Gunn R.N., Worsley K.J., Ma Y., Evans A.C., and Dagher A. A statistical method for the analysis of positron emission tomography neuroreceptor ligand data. NeuroImage 12 (2000) 245-256
6. Bachevalier J., and Mishkin M. Visual recognition impairment follows ventromedial but not dorsolateal prefrontal lesions in monkeys. Behav. Brain Res. 20 3 (1986) 249-261
7. Badgaiyan R.D., Schacter D.L., and Alpert N.M. Priming of new associations: a PET study. NeuroReport 14 18 (2003) 2475-2479
8. Berridge K.C., and Robinson T.E. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?. Brain Res. Rev. 28 3 (1998) 309-369
9. Breier A., Su T.P., Saunders R., Carson R.E., Kolachana B.S., deBartolomeis A., Weinberger D.R., Weisenfeld N., Malhotra A.K., Eckelman W.C., and Pickar D. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc. Natl. Acad. Sci. U. S. A. 94 6 (1997) 2569-2574
10. Buchsbaum M.S., Christian B.T., Lehrer D.S., Shi B., Narayanan T., Mukherjee J., and Mantil J. 18F-fallypride Binding in Never-medicated Patients with Schizophrenia (2004), American Psychiatric Association, New York, NY
11. Byne W., Buchsbaum M.S., Mattiace L.A., Hazlett E.A., Kemether E., Elhakem S.L., Purohit D.P., Haroutunian V., and Jones L. Postmortem assessment of thalamic nuclear volumes in subjects with schizophrenia. Am. J. Psychiatry 159 1 (2002) 59-65
12. Chou Y.H., Halldin C., and Farde L. Effect of amphetamine on extrastriatal D2 dopamine receptor binding in the primate brain: a PET study. Synapse 38 2 (2000) 138-143
13. Christian B.T., Narayanan T.K., Shi B.Z., and Mukherjee J. Quantitation of striatal and extrastriatal D-2 dopamine receptors using PET imaging of [F-18]fallypride in nonhuman primates. Synapse 38 1 (2000) 71-79
14. Christian B.T., Narayanan T., Shi B., Morris E.D., Mantil J., and Mukherjee J. Measuring the in vivo binding parameters of F-18 -fallypride in monkeys using a PET multiple-injection protocol. J. Cereb. Blood Flow Metab. 24 3 (2004) 309-322
15. Delforge J., Bottlaender M., Loc'h C., Guenther I., Fuseau C., Bendriem B., Syrota A., and Maziere B. Quantitation of extrastriatal D2 receptors using a very high-affinity ligand (FLB 457) and the multi-injection approach. J. Cereb. Blood Flow Metab. 19 5 (1999) 533-546
16. de Paulis T. The discovery of epidepride and its analogs as high-affinity radioligands for imaging extrastriatal dopamine D-2 receptors in human brain. Curr. Pharm. Design 9 8 (2003) 673-696
17. Endres C.J., and Carson R.E. Assessment of dynamic neurotransmitter changes with bolus or infusion delivery of neuroreceptor ligands. J. Cereb. Blood Flow Metab. 18 11 (1998) 1196-1210
18. Fecteau J.H., Bell A.H., and Munoz D.P. Neural correlates of the automatic and goal-driven biases in orienting spatial attention. J. Neurophysiol. 92 3 (2004) 1728-1737
19. Friston K.J., Malizia A.L., Wilson S., Cunningham V.J., Jones T., and Nutt D.J. Analysis of dynamic radioligand displacement or "activation" studies. J. Cereb. Blood Flow Metab. 17 1 (1997) 80-93
20. Gunn R.N., Lammertsma A.A., Hume S.P., and Cunningham V.J. Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. NeuroImage 6 4 (1997) 279-287
21. Hazlett E.A., Buchsbaum M.S., Kemether E., Bloom R., Platholi J., Brickman A.M., Shihabuddin L., Tang C., and Byne W. Abnormal glucose metabolism in the mediodorsal nucleus of the thalamus in schizophrenia. Am. J. Psychiatry 161 2 (2004) 305-314
22. Kaasinen V., Aalto S., Nagren K., and Rinne J.O. Expectation of caffeine induces dopaminergic responses in humans. Eur. J. Neurosci. 19 8 (2004) 2352-2356
23. Kessler R.M., Whetsell W.O., Ansari M.S., Votaw J.R., Depaulis T., Clanton J.A., Schmidt D.E., Mason N.S., and Manning R.G. Identification of extrastriatal dopamine D2 receptors in postmortem human brain with I-125 epidepride. Brain Res. 609 1-2 (1993) 237-243
24. Koepp M.J., Gunn R.N., Lawrence A.D., Cunningham V.J., Dagher A., Jones T., Brooks D.J., Bench C.J., and Grasby P.M. Evidence for striatal dopamine release during a video game. Nature 393 6682 (1998) 266-268
25. Laberge D., and Buchsbaum M.S. Positron emission tomographic measurements of pulvinar activity during an attention task. J. Neurosci. 10 2 (1990) 613-619
26. Lammertsma A.A., and Hume S.P. A simplified reference tissue model for PET receptor studies. J. Nucl. Med. 37 5 (1996) 1013
27. Laruelle M., AbiDargham A., vanDyck C.H., Gil R., Dsouza C.D., Erdos J., McCance E., Rosenblatt W., Fingado C., Zoghbi S.S., Baldwin R.M., Seibyl J.P., Krystal J.H., Charney D.S., and Innis R.B. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc. Natl. Acad. Sci. U. S. A. 93 17 (1996) 9235-9240
28. Lehrer D., Christian B.T., Mantil J., Murray A., Buchsbaum B.R., Oakes T., Byne W., Kemether E.M., and Buchsbaum M.S. Thalamic and prefrontal FDG uptake in never-medicated patients with schizophrenia. Am. J. Psychiatry 162 (2005) 931-938
29. Maldjian J.A., Laurienti P.J., Kraft R.A., and Burdette J.H. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. NeuroImage 19 3 (2003) 1233-1239
30. Morris E.D., Fisher R.E., Alpert N.M., Rauch S.L., and Fischman A.J. In vivo imaging of neuromodulation using positron emission tomography: optimal ligand characteristics and task length for detection of activation. Hum. Brain Mapp. 3 1 (1995) 35-55
31. Morris E.D., Yoder K.K., Wang C., Normandin M.D., Zheng Q.-H., Mock B., Muzic R.F., and Froehlich J.C. ntPET: A new application of PET imaging for characterizing the kinetics of endogenous neurotransmitter release. Mol. Imaging. 4 4 (2005) 473-489
32. Mukherjee J., Yang Z.Y., Lew R., Brown T., Kronmal S., Cooper M.D., and Seiden L.S. Evaluation of d-amphetamine effects on the binding of dopamine D-2 receptor radioligand, F-18-fallypride in nonhuman primates using positron emission tomography. Synapse 27 1 (1997) 1-13
33. Mukherjee J., Christian B.T., Dunigan K.A., Shi B.Z., Narayanan T.K., Satter M., and Mantil J. Brain imaging of F-18-fallypride in normal volunteers: blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors. Synapse 46 3 (2002) 170-188
34. Mukherjee J., Christian B.T., Narayanan T.K., Shi B.Z., and Collins D. Measurement of d-amphetamine-induced effects on the binding of dopamine D-2/D-3 receptor radioligand, F-18-fallypride in extrastriatal brain regions in non-human primates using PET. Brain Res. 1032 1-2 (2005) 77-84
35. Muzic R.F., and Cornelius S. COMKAT: compartment model kinetic analysis tool. J. Nucl. Med. 42 4 (2001) 636-645
36. Okauchi T., Suhara T., Maeda J., Kawabe K., Obayashi S., and Suzuki K. Effect of endogenous dopamine on extrastriatal C-11 FLB 457 binding measured by PET. Synapse 41 2 (2001) 87-95
37. Pakkenberg B. The volume of the mediodorsal thalamic nucleus in treated and untreated schizophrenics. Schizophr. Res. 7 2 (1992) 95-100
38. Pappata S., Dehaene S., Poline J.B., Gregoire M.C., Jobert A., Delforge J., Frouin V., Bottlaender M., Dolle F., Di Giamberardino L., and Syrota A. In vivo detection of striatal dopamine release during reward: a PET study with [C-11]raclopride and a single dynamic scan approach. NeuroImage 16 4 (2002) 1015-1027
39. Popken G.J., Bunney W.E., Potkin S.G., and Jones E.G. Subnucleus-specific loss of neurons in medial thalamus of schizophrenics. Proc. Natl. Acad. Sci. U. S. A. 97 16 (2000) 9276-9280
40. Pruessner J.C., Champagne F., Meaney M.J., and Dagher A. Dopamine release in response to a psychological stress in humans and its relationship to early life maternal care: a positron emission tomography study using [C-11]raclopride. J. Neurosci. 24 11 (2004) 2825-2831
41. Rieck R.W., Ansari M.S., Whetsell W.O., Deutch A.Y., and Kessler R.M. Distribution of dopamine D-2-like receptors in the human thalamus: autoradiographic and PET studies. Neuropsychopharmacology 29 2 (2004) 362-372
42. Seber G.A.F., and Wild C.J. Nonlinear Regression (1989), Wiley, New York
43. Shipp S. The brain circuitry of attention. Trends Cogn. Sci. 8 5 (2004) 223-230
44. Slifstein M., Narendran R., Hwang D.R., Sudo Y., Talbot P.S., Huang Y.Y., and Laruelle M. Effect of amphetamine on [F-18]fallypride in vivo binding to D-2 receptors in striatal and extrastriatal regions of the primate brain: single bolus and bolus plus constant infusion studies. Synapse 54 1 (2004) 46-63
45. Talvik M., Nordstrom A.L., Olsson H., Halldin C., and Farde L. Decreased thalamic D-2/D-3 receptor binding in drug-naive patients with schizophrenia: a PET study with C-11 FLB 457. Int. J. Neuropsychopharmacol. 6 4 (2003) 361-370
46. Tzourio-Mazoyer N., Landeau B., Papathanassiou D., Crivello F., Etard O., Delcroix N., Mazoyer B., and Joliot M. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. NeuroImage 15 1 (2002) 273-289
47. Watanabe Y., and Funahashi S. Neuronal activity throughout the primate mediodorsal nucleus of the thalamus during oculomotor delayed-responses: I. Cue-, delay-, and response-period activity. J. Neurophysiol. 92 3 (2004) 1738-1755
48. Watson C.C. New, faster, image-based scatter correction for 3D PET. IEEE Trans Nucl. Sci. 47 4 (2000) 1587-1594
49. Yasuno F., Suhara T., Okubo Y., Sudo Y., Inoue M., Ichimiya T., Takano A., Nakayama K., Haildin C., and Farde L. Low dopamine D-2 receptor binding in subregions of the thalamus in schizophrenia. Am. J. Psychiatry 161 6 (2004) 1016-1022
50. Yoder K.K., Wang C.Z., and Morris E.D. Change in binding potential as a quantitative index of neurotransmitter release is highly sensitive to relative timing and kinetics of the tracer and the endogenous ligand. J. Nucl. Med. 45 5 (2004) 903-911
51. Young K.A., Manaye K.F., Liang C.L., Hicks P.B., and German D.C. Reduced number of mediodorsal and anterior thalamic neurons in schizophrenia. Biol. Psychiatry 47 11 (2000) 944-953
52. Zhou Y., Endres C.J., Brasic J.R., Huang S.C., and Wong D.F. Linear regression with spatial constraint to generate parametric images of ligand-receptor dynamic PET studies with a simplified reference tissue model. NeuroImage 18 4 (2003) 975-989